Clinical Trial Update: Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating sotagliflozin to slow kidney function decline in adults with Type 1 diabetes and diabetic kidney disease, with recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy
• Heart Failure
• Type 1 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Alessandro Doria | Conditions: Diabetic Nephropathies, Kidney Failure, Chronic | Phase 3 | Status: RECRUITING